Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000210390 | SCV002208941 | uncertain significance | not provided | 2023-10-07 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 144 of the EMC1 protein (p.Ala144Thr). This variant is present in population databases (no rsID available, gnomAD 0.01%). This missense change has been observed in individual(s) with retinal dystrophy (PMID: 23105016). ClinVar contains an entry for this variant (Variation ID: 224802). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt EMC1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Center for Genomic Medicine, |
RCV003989504 | SCV004806933 | likely benign | Cerebellar atrophy, visual impairment, and psychomotor retardation; | 2024-03-26 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000210390 | SCV000266487 | uncertain significance | not provided | 2013-02-01 | no assertion criteria provided | literature only | |
Faculty of Health Sciences, |
RCV001257808 | SCV001434686 | pathogenic | Autosomal recessive retinitis pigmentosa | 2012-10-26 | no assertion criteria provided | literature only |